ID   MES-OV/TxT50
AC   CVCL_CZ96
SY   MESOV TxT50; MESOVTxT50
DR   cancercelllines; CVCL_CZ96
DR   GEO; GSM95468
DR   Progenetix; CVCL_CZ96
DR   Wikidata; Q54905247
RX   PubMed=16382445;
CC   Selected for resistance to: ChEBI; CHEBI:4672; Docetaxel anhydrous (Taxotere).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_CZ92 ! MES-OV
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 05-10-23; Version: 6
//
RX   PubMed=16382445; DOI=10.1002/gcc.20300;
RA   Wang Y.C., Juric D., Francisco B., Yu R.X., Duran G.E., Chen G.K.,
RA   Chen X., Sikic B.I.;
RT   "Regional activation of chromosomal arm 7q with and without gene
RT   amplification in taxane-selected human ovarian cancer cell lines.";
RL   Genes Chromosomes Cancer 45:365-374(2006).
//